Life Sciences and Pharmaceuticals

We partner with global life sciences and pharmaceutical companies to design and commission manufacturing and research facilities. Our multidisciplinary teams provide tailored solutions that enable the rapid, safe, and sustainable delivery of vital drugs, therapies, and products.  

Life sciences and pharmaceutical challenges: compliance, sustainability, and speed to market 

The life sciences and pharmaceutical sector faces mounting pressures on capital projects, driven by the need to deliver breakthrough therapies and medicines in Good Manufacturing Process (GMP) regulated environments, compounded by net-zero targets, supply chain constraints, and regulatory and geopolitical complexity. Every capital project must secure a robust license to operate, ensuring compliance, quality, and long-term value. 
 
Novel therapies like gene and cell therapy are pushing facility design boundaries. These treatments require flexible, scalable, and highly compliant environments delivered quickly. When design, engineering, and validation are managed separately, projects risk delays, cost overruns, and reduced asset performance. 
 
Clients are rethinking project delivery in response: 

• Unified delivery models: Streamlining delivery to reduce fragmentation, accelerate time to market, and improve efficiency and quality. 
• Compliance as an enabler: Treating compliance as a strategic investment that supports decarbonization and long-term performance. 
• Future-ready assets: Designing facilities to meet current standards while remaining adaptable to scientific advances and evolving environmental requirements.